Sentinel lymph node biopsy in breast cancer

Area of Science:

• Oncology
• Surgical Oncology
• Pathology

Background:

• Axillary lymph node status is critical for breast cancer staging and treatment decisions.
• Historically, axillary lymph node dissection was the standard, but it carries significant morbidity.
• Sentinel lymph node biopsy (SLNB) has emerged as a less invasive alternative.

Purpose of the Study:

• To provide a comprehensive review of sentinel lymph node biopsy (SLNB) for invasive breast cancer.
• To discuss the historical context, evidence supporting its accuracy and safety, and technical considerations.
• To emphasize the multidisciplinary collaboration required for successful SLNB.

Main Methods:

• Review of historical data and recent literature on SLNB in breast cancer.
• Analysis of studies evaluating the accuracy, safety, and applicability of SLNB.
• Description of the technical aspects and procedural requirements for performing SLNB.

Main Results:

• SLNB is a widely accepted and accurate method for axillary lymph node staging in invasive breast cancer.
• The procedure has demonstrated high identification rates and low false-negative rates when performed by experienced operators.
• Successful implementation requires close collaboration between surgeons, pathologists, radiologists, and nuclear medicine specialists.

Conclusions:

• Sentinel lymph node biopsy is a safe and effective method for axillary staging in invasive breast cancer.
• Achieving optimal outcomes with SLNB necessitates a high operator identification rate, low false-negative rate, and strong multidisciplinary teamwork.
• Continued understanding and refinement of SLNB techniques are essential for patient care.